MONROVIA/DAKAR (Reuters) – Liberia said on Tuesday it would treat two infected doctors with the scarce experimental Ebola drug ZMapp, the first Africans to receive the treatment, while authorities in Spain said a 75-year-old priest had died of the disease.
Based at the Middlebury Institute of International Studies, The WIP® Internet news service is your global source for women's perspectives. Connecting you to the world through our Feature Articles, Byline Portal, and Current Headlines, The WIP promotes diversity and is not associated with any particular religious, political, or cultural affiliation. We provide an opportunity to balance the under-representation of women journalists and strive to bring together divergent cultures and opinions in solution-based dialogue.
